Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Atoderm SOS Spray
- Development stage
- Unknown
- Lead developer
- Bioderma
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Atoderm SOS Spray is a topical anti-itching cosmeceutical product developed by Bioderma (a brand of NAOS). It is specifically formulated to provide rapid relief from pruritus (itching) associated with atopic dermatitis and other inflammatory skin conditions. The product features a proprietary Skin Relief Technology incorporating ambora extract and epigallocatechin gallate (EGCG), which are designed to inhibit the release of itch-inducing mediators such as Thymic Stromal Lymphopoietin (TSLP) and Nerve Growth Factor (NGF). The formulation also includes enoxolone for its anti-inflammatory properties, Vitamin PP (niacinamide) and squalane to replenish skin lipids and restore the barrier, and a Skin Barrier Therapy™ Complex to prevent the adhesion of Staphylococcus aureus. It has been the subject of clinical investigation led by Prof. HON Kam Lun Ellis to evaluate its efficacy in reducing itch and improving quality of life in children with moderate-to-severe eczema.
- Brand names
- Atoderm SOS Spray
- Other names
- Atoderm SOS
02
Targets
GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on Atoderm SOS Spray.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Atoderm SOS Spray.